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Abstract
Background: The creation of accurate quantitative Systems Biology Markup
Language (SBML) models is a time-intensive, manual process often complicated by
the many data sources and formats required to annotate even a small and well-
scoped model. Ideally, the retrieval and integration of biological knowledge for
model annotation should be performed quickly, precisely, and with a minimum of
manual effort.
Results: Here we present rule-based mediation, a method of semantic data
integration applied to systems biology model annotation. The heterogeneous data
sources are first syntactically converted into ontologies, which are then aligned to a
small domain ontology by applying a rule base. We demonstrate proof-of-principle
of this application of rule-based mediation using off-the-shelf semantic web
technology through two use cases for SBML model annotation. Existing tools and
technology provide a framework around which the system is built, reducing
development time and increasing usability.
Conclusions: Integrating resources in this way accommodates multiple formats with
different semantics, and provides richly-modelled biological knowledge suitable for
annotation of SBML models. This initial work establishes the feasibility of rule-based
mediation as part of an automated SBML model annotation system.
Availability: Detailed information on the project files as well as further information
on and comparisons with similar projects is available from the project page at
http://cisban-silico.cs.ncl.ac.uk/RBM/.
Background
Annotation of systems biology models
A quantitative model of molecular systems describes the dynamics of the interactions
between biological entities involved. Such modelling is central to systems biology.
Models and experiments are typically refined iteratively: models provide useful feed-
back to experimentalists, who in turn pass their results back to improve the model.
The creation of systems biology models, such as those written in Systems Biology
Markup Language (SBML) [1] or CellML [2], is a primarily manual process. Making
use of the many data sources and formats relevant to model development is time-con-
suming for modellers. While a small number of core databases can be used to retrieve
Lister et al. Journal of Biomedical Semantics 2010, 1(Suppl 1):S3
http://www.jbiomedsem.com/content/1/S1/S3 JOURNAL OF
BIOMEDICAL SEMANTICS
© 2010 Lister and Wipat; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.a large amount of biological information relevant to the modeller, accessing the “long
tail” of information stored in other resources is where manual processes become
difficult.
Systems biology models can contain both the quantitative information required to
run the simulation and biologically-meaningful annotation. However, while models
often include the mathematical information required for simulations, they are not
required to contain explicit information about the full biological context. Annotation
provides a description of how a model has been generated and defines the biology of
its components in a computationally-accessible fashion. While the presence of biologi-
cal annotation aids efficient exchange, reuse, and integration of models, simulation
does not require annotation and therefore such information is often limited or lacking.
A well-annotated model is useful for simulation, as an input in other computational
tasks and as a reference for researchers. A model with limited annotation is frequently
useful only to the modeller who created it due to the often ambiguous naming
schemes and lack of biological context [3,4].
Biological annotation in SBML is structured according to the Minimal Information
Required in the Annotation of Biochemical Models (MIRIAM) specification [3]. There
are three parts to MIRIAM: a recommended URI-based structure for compliant anno-
tations, a set of resources to generate and interpret those URIs and a checklist of mini-
mal information requested in the annotation of biological models. While other
annotations are allowed within the specification, it is primarily the MIRIAM annota-
tions which are relevant to the work presented here. MIRIAM annotations are URIs
added to models in a standardised way, and which link external resources such as
ontologies or data sources to a model. MIRIAM provides a standard structure for
explicit links between the mathematical and biological aspects of a model. Aids to
model annotation exist [5-9], but rely extensively on the expert knowledge of the mod-
eller for identification of appropriate additions. There is a need for computational
approaches that automate the integration of multiple sources to enable the model
annotation process.
Data integration in the life sciences
The integration of life sciences data remains an ongoing challenge due to the multi-
tude of data sources and formats differing both in syntax and semantics. Errors in data
integration can occur when data sources do not describe their information with a
shared semantics [10]. The problems of, and historical approaches to, syntactic and
semantic data integration have been well described [11,12]. Syntactic heterogeneity is
when data of interest is available in different formats, and is generally resolved through
the use of a common schema (such as with data warehousing techniques) or through
translation of a single query into multiple queries understandable by each of the
underlying data sources (query translation). Semantic heterogeneity describes the dif-
ference in the meaning of data among different data sources. A high level of semantic
heterogeneity makes direct mapping difficult, often requiring further information to
ensure a successful mapping. Semantic data integration is intended to resolve both syn-
tactic and semantic heterogeneity and can allow a richer description of biology than is
possible with syntactic methods, which often align data by linking structural units such
as XSD components or table and row names.
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between classes in two or more ontologies [13]. In the simplest case of ontology map-
ping a source ontology is mapped directly onto a second, target, ontology. If only two
ontologies need to be reconciled, ontology mapping is an effective strategy, as only two
conceptualisations need to be compared. However, the complexity increases as more
ontologies are added, rapidly limiting this method’s usefulness. More complex mapping
methods include mediator-based approaches, where a number of source ontologies are
individually mapped t oas i n g l et a r g e t ,o rcore ontology. Usually, a core ontology is a
description of the domain of interest rather than a description of the syntactic struc-
ture of the data. Previous work with ontology mapping and other semantic data
integration methodologies in the life sciences [12,14-18] are discussed further at
http://cisban-silico.cs.ncl.ac.uk/RBM/.
Semantic data integration for model annotation
Systems biology model annotation can be time-consuming, as there are many
resources for model annotation; the modeller may not even be aware of all of them.
Accordingly, annotation is often slow and difficult. Current systems biology model
annotation tools rely mainly on syntactic data integration methods such as query trans-
lation. While large amounts of data can be gathered and queried in this manner, the
integration process is limited to resolving formatting differences without attempting to
address semantic heterogeneity. While existing tools for model annotation are useful,
semantic data integration methods can be used to resolve differences in the meaning
of the data.
Therefore, in the work presented here we have developed rule-based mediation as an
approach to semantic data integration for systems biology. In rule-based mediation, we
use a set of syntactic ontologies which result from the conversion of a single data format
into OWL constrained by Description Logics (OWL-DL) [19]. These syntactic ontolo-
gies are then individually linked to a core ontology, which describes the domain of inter-
est. In rule-based mediation, a core ontology is completely independent of any of the
syntactic ontologies, unlike traditional methods where one ontology type is created as a
view of the other, such as pure global-as-view or local-as-view. However, rule-based
mediation is similar to approaches such as the BYU Global-Local as View (BGLaV) [20].
Rule-based mediation allows both the straightforward addition of new syntactic ontolo-
gies as well as the maintenance of the core ontology as an independent entity.
In rule-based mediation, we materialise the data in the core ontology by using a set
o fr u l e st ot r a n s l a t et h ed a t af r o mt h es y n t a c t i co n t o l o g i e st ot h ec o r eo n t o l o g y .T h i s
avoids the complex query translation algorithms required by the BGLaV approach.
In short, rule-based mediation has a number of defining features:
￿ the data from syntactically and semantically different data sources are materia-
lised within a core ontology for easy access and stable querying;
￿ the core ontology is a semantically-meaningful model of the biological domain of
interest;
￿ implementation can be performed using off-the-shelf tools and mapping
languages.
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Rule-based mediation
In rule-based mediation, syntactic heterogeneity is resolved through the conversion of
disparate data formats into syntactic ontologies. The data from the syntactic ontologies
is then mapped to the core ontology, which stores the data in a semantically-homoge-
neous way. The core ontology, which describes the biological domain of interest, can
then be queried and reasoned over. There are three main parts to rule-based media-
tion: the syntactic ontologies for describing the disparate data formats, the core ontol-
ogy, and the mapping rules for linking the syntactic ontologies to the core ontology.
We have used standard languages for creating (e.g. Web Ontology Language (OWL)
[19]), querying (e.g. Semantic Query-Enhanced Web Rule Language (SQWRL) [21]),
and mapping (e.g. Semantic Web Rule Language (SWRL) [22]) ontologies. While other
ontology languages such as the Open Biomedical Ontologies (OBO) [23] are also
widely used in the life sciences, they do not provide the same level of support for auto-
mated semantic reasoning as OWL-DL [24].
Syntactic ontologies
As with other mediator-based approaches, in rule-based mediation the data formats are
converted to syntactic ontologies. In our approach, the purpose of syntactic ontologies
is to describe the data formats as well as isolate syntactic variability so that the core
ontology models only the semantics of the data being integrated. Though this method
can use any ontological format, here a syntactic ontology is a conversion of a non-
OWL format such as XML into OWL-DL. Information from one or more data sources
sharing the same data format is loaded into that format’s syntactic ontology. A syntac-
tic ontology used in this way allows both the import of data to the core ontology and
the export of new information to the underlying data sources.
Core ontology
Often, mediator-based approaches build a core ontology as a union of syntactic ontolo-
gies rather than as a semantically-rich description of the research domain in its own
right [25-27]. In contrast, for rule-based mediation we use a core ontology, which is a
biologically-relevant, tightly-scoped, logically-rigorous description of the semantics of
the research domain. The core ontology describes the domain, in this case the specifics
of the biology of interest. The core ontology may be created for this purpose or drawn
from existing ontologies.
Because the core ontology is abstracted away from data formats, importing new data
sources is made easier. Furthermore, the process of adding to the core ontology is sim-
plified: each new mapping, class, or data import is incremental, without the need for
large-scale changes. The richness of the core ontology depends on the type of biologi-
cal questions that it has been created to answer; a detailed ontology may have higher
coverage of the research domain, but may take longer to develop and reason over.
In contrast to global-as-view or local-as-view approaches, where either the target or
source ontologies are entirely described using views of the other, the methods used in
rule-based mediation provide a way to decouple syntactic and semantic heterogeneity
and allow the core and syntactic ontologies to remain distinct. Additionally, rule-based
mediation maps and loads data directly into the core ontology, allowing simplified
querying via the use of standard tools, mapping and querying languages. Since the core
ontology is more than just the entailment of a set of syntactic ontologies, it could be
Lister et al. Journal of Biomedical Semantics 2010, 1(Suppl 1):S3
http://www.jbiomedsem.com/content/1/S1/S3
Page 4 of 17used for more than just rule-based mediation. Being a semantically-rich model of a
research domain, it could also be used as a standalone ontology for marking up data
or as a reference model of its biological domain. Furthermore, due to its independence
from the syntactic ontologies, it is much more flexible with respect to changes.
Mapping between syntactic and core ontologies
The mapping in rule-based mediation is defined with the OWL-DL-based SWRL rule
language. SWRL divides rules into a antecedent for describing the initial conditions of
the rule, and a consequent for describing the target of the rule. Whenever the antece-
dent of the rule is true, the conditions in the consequent must also hold. When map-
ping from the syntactic ontologies to core ontologies, the antecedent of the rule is
derived from a syntactic ontology, while the consequent corresponds to the mapped
concept within the core ontology. Once data have been integrated into the core ontol-
ogy, the knowledge contained within the core ontology can be reasoned over and quer-
ied, and the query response formatted according to a suitable syntactic ontology. The
quality of the data exported back to a syntactic ontology, and in turn to a base format,
is dependent upon both the quality of the mappings to the syntactic ontology and the
syntactic ontology’s scope. If either the mappings are incomplete, or the underlying
data format has no way of describing the new data, the export will lack information.
SQWRL is a rule language based on SWRL, and is used for querying an OWL ontol-
ogy and formatting the query response. In a way analogous with how SQL SELECT
statements are used in a relational database management system, SQWRL presents the
user with the results of a query, but does not store those results back in the ontology.
Within the context of this paper, SQWRL queries are used to test the structure of a
query or rule, and to illustrate interesting, but indirectly-relevant, queries. If results
should be stored, SWRL mapping rules will save the results within the ontology.
Rule-based mediation in the context of model annotation
Current systems biology model annotation tools have limited access to the semantics
of the models. We have implemented rule-based mediation to address this limitation,
creating a method of model annotation which imports information from data sources
in a semantically- and syntactically-integrated way. This approach retrieves information
that is tailored to the needs of the modeller and more relevant that that retrieved
through syntactic methods. We have used a combination of existing tools, rule lan-
guages and novel mappings to perform proof-of-principle integration for two use cases.
Figure 1 shows rule-based mediation in the context of SBML model annotation.
First, information is syntactically converted into OWL-DL; second, the information is
mapped into a core ontology; third, the core ontology is queried to answer specific bio-
logical questions; and finally, the new information is sent back to an external format, in
this case SBML, via mappings from the core ontology to its syntactic ontology. From a
biological perspective, rule-based mediation produces an integrated view of information
useful for modelling.
In this paper we have extended a quantitative biological SBML model via rule-based
mediation as a proof-of-principle for the methodology. To facilitate the use cases, we
created a core ontology describing a subset of telomere biology. We then used three
standard semantic web tools (XMLTab [28], SWRLTab [29] and SQWRLQueryTab
[30]) to integrate heterogeneous data sources containing information relevant to this
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SBML model, including the provisional identification of information not previously
present in the model. This work demonstrates the feasibility of the approach, the
applicability of the technology and its utility in gaining new knowledge.
Syntactic ontologies for the use cases
Rule-based mediation separates the resolution of syntactic and semantic heterogeneity
into two steps. The first step is the syntactic conversion of a data format into a syntac-
tic ontology. Four data sources were used to create four syntactic ontologies for this
work: BioGRID [31] in PSI-MIF [32] format, Pathway Commons [33] in BioPAX for-
mat, BioModels [34] in SBML format and UniProtKB [35]. For each data format, a sui-
table syntactic ontology was either identified or created. BioModels was used to
retrieve the SBML model to be annotated, while the other three were used as general
data inputs to the integration system. However, BioModels can also be used as a gen-
eral data input, which could result in the identification of links among models. Basic
information on the data formats as well as the numbers of classes, relations and map-
ping rules in their syntactic ontologies is available in Table 1.
Figure 1 Rule-based mediation in the context of SBML model annotation. Non-OWL formats are first
converted into syntactic ontologies. Here, both UniProtKB and BioGRID data are in XML: UniProtKB has its
own schema, while BioGRID uses PSI-MIF. These formats are converted into syntactic ontologies via the
XMLTab. BioPAX, the format used for Pathway Commons, is already in OWL and needs no conversion.
Next, the instances present in the syntactic ontologies are mapped to the core ontology using SWRL.
Finally, querying is performed using SQWRL queries using only core ontology concepts. Information is then
passed through a final syntactic ontology (MFO) into an SBML model.
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senting constraints from SBML, Systems Biology Ontology (SBO) and the SBML man-
ual [36]. MFO has a dual purpose for the presented use cases: firstly, it was used as
the format for the representation of any data stored as SBML and secondly, it was
used to format query responses as SBML.
BioPAX was used in its native OWL-DL format. Information about the network
neighbours of any given Pathway Commons entity can be accessed as a BioPAX docu-
ment written in OWL-DL. Therefore, no additional syntactic ontology was needed
s i n c et h ep o p u l a t e dB i o P A Xo n t o l o g yr e t u r n e df r o man e a r e s tn e i g h b o u rq u e r yc o u l d
be used directly.
The PSI-MIF and UniProtKB syntactic ontologies were created from their XML data
formats. Ontology classes represent element and attribute types, while the data items
themselves are represented with ontology instances. Figure 2 shows an overview of the
classes created for the BioGRID syntactic ontology. As this work was being completed,
Pathway Commons began importing BioGRID data. Therefore in future, Pathway
Commons can be used to retrieve BioGRID data rather than the PSI-MIF syntactic
ontology. However, the PSI-MIF syntactic ontology developed is not redundant: it can
be used to integrate any other PSI-MIF-based data sources. Figure 3 shows an excerpt
of the UniProtKB syntactic ontology. A UniProtKB syntactic ontology was generated
using the UniProtKB XML format. Unambiguous assignment of a UniProtKB primary
accession to a new species in an SBML document provided a useful way to annotate
individual species as well as identify similar proteins. For the use cases, UniProtKB was
primarily useful for localisation and identification information.
Telomere ontology
Once the syntactic ontologies are created, the second step in rule-based mediation is
the creation or identification of a suitable core ontology. Unlike the syntactic ontolo-
gies, which are designed to be OWL-DL representations of the underlying data for-
mats, a core ontology is an explicit description of the semantics of the research
domain. The core ontology created for these use cases is the telomere ontology, which
models the biology relevant to the Proctor et al. model [37] of telomere uncapping.
The telomere ontology was created to describe and aid the identification of pathways,
genes and other biologically-relevant entities involved in ageing processes in yeast.
Figure 4 shows a portion of this ontology. While a comprehensive telomere ontology is
not yet complete, the parts necessary for the use cases have been fully constructed.
Table 1 Basic information about the syntactic ontologies and their mapping rules with
the core ontology.
Data Source Data Format Classes Object Properties Data Properties DL Expressivity Rules
UniProtKB UniProtKB XML 27 24 34 ALEN (D) 11
BioGRID PSI-MIF 26 24 15 ALEN (D) 17
SBML SBML 516 56 44 SHOIN (D) 14*
Pathway Commons BioPAX 41 33 37 ALCHN (D) 11
Pathway Commons differs from the other sources as its format, BioPAX, is already represented in OWL. The ‘’Rules’’
column lists the number of SWRL mapping statements used to link each syntactic ontology with the core ontology. For
the SBML syntactic ontology, the numbers are combined totals of the imported Systems Biology Ontology and MFO.
MFO was used for export only, and therefore its rules are marked with “*’’ to show that these are export rules. Statistics
generated using Protégé 4 (http://protege.stanford.edu/).
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Rule-based mediation was performed for two use cases to show proof-of-principle for
SBML model annotation. The mapping rules from the syntactic ontologies to the telo-
mere ontology were run prior to performing the queries over the data. These rules
populated the telomere ontology with the instance data from the syntactic ontologies.
The telomere ontology, the syntactic ontology, the SWRL mappings, SQWRL queries,
and the SBML model before and after annotation in these use cases are available on
the project page at http://cisban-silico.cs.ncl.ac.uk/RBM/.
In this paper, we consider two methods for enriching an existing model of telomere
uncapping in Saccharomyces cerevisiae. In Use Case 1, we annotate a single SBML spe-
cies with information relevant to the gene RAD9. Adding information to existing
SBML elements at an early stage aids model development and extension prior to
Figure 2 Overview of the PSI-MIF syntactic ontology. The PSI-MIF syntactic ontology is used for
BioGRID data, and was created by the Protégé XMLTab plugin using the PSI-MIF-formatted result of a
query over BioGRID.
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of UniProtKB entries. As with the other syntactic ontologies, instances represent the data itself while
classes represent the structure.
Figure 4 An overview of the telomere ontology. The telomere ontology is the core ontology for the
use cases presented here.
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tions involving the RAD9 protein. This approach resulted in the identification of
model elements as well as a putative match for an enzyme that was not identified in
the original curated model. These examples show how rule-based mediation works in a
systems biology setting. The use cases also show that rule-based mediation successfully
integrates information from multiple sources using existing tools, and that it would be
useful to expand the implementation of this method to larger biological questions and
automated model annotation.
Use Case 1: annotation
Use Case 1 demonstrates the addition of basic information to the species such as
cross-references, SBO annotations, compartment localisations and a recommended
name. For this use case we queried the telomere ontology for information about the S.
cerevisiae query gene RAD9. Queries for proteins possessing ‘rad9’ a san a m eo rs y n o -
nym are stored within the telomere ontology as SWRL rules. An example rule is
shown below. This rule is one of those used to collect all matching telomere ontology
proteins and further declare them specifically as RAD9 proteins:
tuo : Protein(?rules : someEntity) Λ
tuo : synonym(?rules : someEntity, ?rules : s) Λ
swrlb : containslgnoreCase(?rules : s, “rad9”) ®
tuo : Rad9(?rules : someEntity)
T h er u l eq u e r i e st h es y n o n y m so ft h ep r o t ein names within the telomere ontology
for a string matching “rad9”, and declares any matches as RAD9 proteins. In use, this
and related rules uncovered three instances, each from a different data source: one
from Pathway Commons, one from UniProtKB, and one from BioGRID. These three
instances were then declared equivalent. The final step of this use case is to restrict
the instances of RAD9 to the organism of interest, S.cerevisiae.
Once integrated, the information contained within these three instances is then sent
out, using MFO, to a new version of the Proctor et al. SBML model. In order to export
the relevant knowledge to MFO, 14 mapping rules with telomere ontology classes in
the antecedent and MFO classes in the consequent were created. Four of the 14 were
used specifically to create MIRIAM cross-references and SBO terms. The two Proctor
et al. RAD9 species originally contained a single reference to UniProtKB, which was
confirmed by the information retrieved from the telomere ontology. In addition, an
SBO Term and five other MIRIAM annotations from Intact, UniProtKB, Pathway
Commons and SGD were exported.
Use Case 2: interactions
Use Case 2 shows how possible protein-protein interactions can be retrieved to annotate
models. Specifically, interactions involving RAD9 were retrieved from the telomere ontol-
ogy, confirming those already present in the curated model as well as discovering novel
interactions. The Proctor et al. model has four interactions between RAD9 and other pro-
teins, as described in the Proctor et al. column of Table 2. Two of these interactions are
with known proteins (RAD53 and CHK1), and two are with proteins whose identity was
unknown to the modeller (labelled Rad9Kin and ExoX). Importantly, here, rule-based
mediation has provisionally identified of one of those previously unidentified proteins.
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as the putative identity of an enzyme responsible for activation of RAD9. The results of
Use Case 1 are used as part of the input in this use case. The SQWRL query shown below
is for displaying, but not storing, every interaction involving RAD9.
tuo : Rad9(?rules : rad9instance) Λ
tuo : plays(?rules : rad9instance,? rules : participant) Λ
tuo : hasParticipant(?rules : process,? rules : participant) ®
sqwrl : select(?rules : rad9instance,? rules : process)
T h ea b o v eq u e r yi d e n t i f i e si n t e r a c t i o n si nvolving RAD9 instances, and displays the
name of the instance as well as the process in which it is involved. The use of SQWRL
here rather than SWRL allows the more than 270 returned interactions to be viewed.
These results are deliberately not saved in the asserted ontology as many are not
meaningful for the model under study. Instead, the SQWRL query was used to deter-
mine the full set of results, and then SWRL rules were used to filter the interactions
according to those species already present in the model. Protein instances were classi-
fied in a similar way to Use Case 1. The example SWRL query shown below classifies
CHK1 protein instances:
tuo : Protein(?rules : someEntity) Λ
tuo : synonym(?rules : someEntity,? rules :s )Λ
swrlb : containsIgnoreCase(?rules : s, “chkl”) ®
tuo : Chk1(?rules : someEntity)
The combined results from the rule above together with 12 associated rules allowed
four proteins of interest to be classified. Specific interactions of interest were then
identified. The OWL axioms on the telomere ontology class for interactions between
RAD9 and RAD53 are shown below as an example. This class is one of four defined
classes which filter the RAD9 interactions.
Rad9/Rad53 Interactions :
tuo : hasParticipant some (tuo : playedBy some tuo : Rad9) Λ
tuo : hasP articipant some (tuo : playedBy some tuo : Rad53)
Table 2 Summary of interactions retrieved for Use Case 2 against the core telomere
ontology.
Discovered Interaction Partner with P14737 Proctor et al. BioGRID Pathway Commons
Serine/threonine-protein kinase RAD53 (P22216) ✓✓ ✓
Serine/threonine-protein kinase CHK1 (P38147) ✓✓
Serine/threonine-protein kinase MEC1 (P38111) ✓
DNA damage checkpoint control protein RAD17 (P48581) ✓
Rad9Kin (*) ✓
ExoX (*) ✓
All discovered interactions already present in the curated model are shown, together with example interactions from the
curated model that were not discovered (with Rad9Kin and ExoX) and discovered interactions that were not present in
the model (with MEC1 and RAD17). SBML species shown with an asterisk (*) are those which are placeholder species,
and therefore cannot have a match to a real protein. Some interactions are false positives inherent in the data source,
while others are out of scope of the modelling domain of interest and should not be included.
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tion classes.
There are a total of four interactions involving RAD9 in the curated model. Two of
these interactions, with RAD53 and with CHK1, were confirmed. The RAD53 interac-
tion was found in both BioGRID and in Pathway Commons, while the CHK1 interac-
tion was only in Pathway Commons. The other two RAD9 interactions present in the
model include placeholder species, which were created by the modeller to describe
proteins whose identity was unknown. Because these proteins had no defining features,
they could not be directly identified with the same methods used for RAD53 and
CHK1. We provisionally identified one of those placeholder species, marked as ‘Rad9-
Kin’ in the model, as the protein MEC1 using data originating in BioGRID.
In the original curated model, the ‘rad9Kin’ species does not have a UniProtKB pri-
mary accession, as the model author did not know which protein activated RAD9.
However, MEC1 is shown in the telomere ontology as interacting with RAD9 and is
present elsewhere in the curated model reactions. Further, UniProtKB reports MEC1
as a kinase which phosphorylates RAD9. From this information, the model author now
believes that MEC1 could be the correct protein to use as the activator of RAD9 [38].
RAD17 is another example of a protein present in the curated model, but not marked
as an interacting partner of RAD9. However, BioGRID data shows an interaction
between RAD9 and RAD17. This interaction may have been unknown to the modeller,
and it may be that the curated model could be improved by the addition of a RAD9/
RAD17 reaction.
Finally, the rules to export the new information from the telomere ontology to MFO,
as described in Use Case 1, were executed. As a result, new species, reactions, and
MIRIAM annotations were added to a new version of the original SBML model. Exist-
ing SBML species gained MIRIAM annotations, names and SBO terms. Two new reac-
tions were also added: RAD9 with RAD17, and RAD9 with MEC1. The former was
chosen to demonstrate how the formation of a protein complex is mapped back to
MFO, and the latter was chosen as an example of the mapping of an interaction about
w h i c hl e s si sk n o w n .F u r t h e r m o r e ,s i n c eMEC1 is a candidate for the value of the
‘Rad9Kin’ species in the curated model, a skeleton reaction in the annotated version of
the curated model acts as a placeholder for manual curation. Further work by the
modeller could then fill in the base reaction, species and annotation, including para-
meters, initial values and rate constants.
Discussion
We have created a new method of semantic data integration called rule-based media-
tion that reduces the amount of manual effort required to annotate a systems biology
model, and which allows access to the underlying semantics of the data. Rule-based
mediation makes use of a semantically-rich core ontology together with mappings to
and from syntactic ontologies that represent the data sources of interest. New data
sources can be easily inserted without modifying the biologically-relevant core ontol-
ogy. Separation of syntactic integration and semantic description of the biology is
robust to changes to both the syntactic ontologies and the core ontology. The use of
existing tools decreases development time and increases the applicability of this
approach for future projects.
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tegies. Global-as-view mapping defines a core ontology as a function of the syntactic
ontologies rather than as a semantically-rich description of the research domain in its
own right, though the level of dependence of the core ontology can vary [25-27]. How-
ever, defining a core ontology merely as a model of a set of data sources limits global-
as-view’s usefulness, as the ontology becomes brittle with respect to the addition of
new data sources and new formats. With local-as-view, the core ontology is indepen-
dent of the syntactic ontologies, and the syntactic ontologies themselves are described
as views of the core ontology. However, query complexity increases quickly with local-
as-view approaches, and data sources need to be forced into the structure of the global
core ontology [20]. Both methods are limited in their ability to describe the nuances of
the biological concepts being studied. Such information is often not captured, either
because the syntactic ontologies are intended to model the data sources in global-as-
view or, as in local-as-view, because the syntactic ontologies are just views over a core
ontology, restricting the description of both the core biology and the syntax. Rule-
based mediation solves these problems by separating the core and syntactic ontologies,
benefiting from their independence.
Syntactic heterogeneity
Syntactic heterogeneity was resolved by converting the four data formats into OWL-
DL. When performing this step, issues of scalability, scope and provenance were con-
sidered carefully. For instance, XMLTab is not an ideal choice for long-term use, as it
does not scale well, and cannot load multiple XML files at once into a single syntactic
ontology. Additionally, it is not clear that the XMLTab project is in active develop-
ment. However, tools such as the SWRLAPI’s XMLMapper [39] or Krextor [40] may
provide viable alternatives. Likewise, rules are currently manually-generated, which also
scales poorly. This can be addressed by automatically generating many rules. While we
have made extensive use of pre-existing applications, plugin, and libraries, we can fore-
see a time in the very near future where we will reach the limit of some of these tech-
nologies with respect to ontology size or the amount of imported data. Particularly, the
large number of instances required in a larger-scale semantic data integration project
will most likely necessitate the use of a database back-end for the ontologies. Some
technologies are available for storing instances from ontologies within a database
schema, such as Jena’s database libraries [41], the Protégé database back-end [42], or
that followed by Sahoo et al.[17].
Secondly, there are limitations in describing data provenance using the SBML stan-
dard syntax. When new MIRIAM annotations are added to an SBML model, there is
n ow a yo fs t a t i n gw h i c hp r o c e d u r ea d d e dt h ea n n o t a t i o n s ,o rt h ed a t et h e yw e r e
added. At a minimum, the addition of the software type, version number and date on
which the information was added should be included. The authors have been in dis-
cussions with the SBML community since the 2009 Hackathon to determine how best
to solve this problem. Until this issue is resolved, no provenance information is
included in the newly-annotated models.
The final issue to consider is scope: many data sources are able to export in multiple
formats, but such formats may not provide the same set of information. Even though a
particular format might be available, it may not contain the complete set of
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many formats including BioPAX and SBML, and models from BioModels could be
loaded into the telomere ontology via BioPAX. However, the native format for most
B i o M o d e l si sS B M L ,a n dc o n v e r s i o nf r o mt his format is not lossless: for example,
quantitative data such as rate laws are not supported in BioPAX. Therefore if BioMo-
dels database entries are to be annotated, input via MFO is best. Because the choice of
data format can influence the type of data ultimately entering the core ontology, this
syntactic phase of integration can also influence the semantic resolution step of rule-
based mediation.
Semantic heterogeneity
Semantic heterogeneity in rule-based mediation is resolved through precise mapping
rules and a well-written core ontology. The biological domain of interest must be mod-
elled appropriately, and the incoming data must be linked to appropriate concepts in
the core ontology. However, semantic data integration is not simple, and there are a
number of issues to be addressed when performing this step.
Firstly, in order to assert equivalences between instance data from the various data
sources, the authors manually applied the owl:sameAs construct. This method is ill-
suited to automated procedures. However, tool and reasoning support for OWL 2,
now a W3C Proposed Recommendation [43], is growing. With OWL 2, some immi-
nent advances such as the hasKey [44] construct will allow automation in this area.
Secondly, rules linking syntactic ontologies to the core ontology can be quite com-
plex. Many rules in the work presented here have 14 or more clauses, but once a rule
is in place, its execution is efficient and does not often need to be repeated. However,
there are some limitations in the rule languages used. For instance, SWRL allows the
creation of new ontology instances during rule execution. While this is useful, it can
lead to unexpected results such as multiple identical individuals being created each
time the rule is run. These limitations can be ameliorated through more sophisticated
usages of OWL and SWRL tools. One such tool already used within the MFO project
is the OWLAPI [45], which allows finer control over ontologies and their mapping and
reasoning. Greater use of the SWRLAPI [39] might also address these limitations.
A type of semantic heterogeneity that can be difficult for any integration system to
address is the use of two distinct data items from the one data source to describe a
single concept from another, e.g. where a protein is described by two UniProtKB
entries but only a single SBML species. In rule-based mediation, we represent this het-
erogeneity rather than reconcile it. However, such cases have not been created by this
work, only present via imports from existing sources. The opposite case, where a single
data item is used to annotate multiple concepts, is common in SBML, for example
with active or inactive species. This is specifically allowed by the telomere ontology.
Finally, an understanding of the semantics of the data formats is required when
developing the export mapping rules from the core ontology to a syntactic ontology. A
simple case would be how different formats define similar concepts. For instance, a
protein in BioPAX is strictly defined as having only one polypeptide chain, while a pro-
tein in UniProtKB can consist of multiple chains. A more complex case is when two
concepts, e.g. two interaction instances, have virtually indistinguishable properties,
making it difficult for automated procedures to know which interaction to use.
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to more than one concept in the syntactic ontology. For example, in most systems
biology formalisms there is a clear delineation between a protein as an abstract con-
cept and a protein as a specific interactor in a reaction. Within SBML, this is defined
using the speciesType or species elements for the concept of a protein, and
speciesReference for the interactor. Within BioPAX level 2, this is exemplified by
physicalEntity and physicalEntityParticipant. A similar dichotomy
exists within the telomere ontology. When converting the information retrieved in Use
Case 1 back to SBML, these considerations need to be taken into account. Ultimately,
the use of speciesType is not ideal, as future versions of SBML will have a different
way of modelling such concepts [46]. Therefore, to align with future versions of SBML
as well as to make the mapping simple, the best solution is to link to the appropriate
attributes of an SBML species element.
Conclusions
Manual SBML model creation and annotation can be a slow process, and is made
more difficult by the large number of data sources relevant to modelling. We have
shown that rule-based mediation is capable of resolving both syntactic and semantic
heterogeneity. Specifically, addressing syntax and semantics separately allows the
straightforward addition of new information; the modelling of the biological domain of
interest without any knowledge of underlying formats; and simple manipulation of the
mapping rules using off-the-shelf tools.
We showed a proof-of-principle application of rule-based mediation to systems biol-
ogy model annotation, producing a new SBML model containing new MIRIAM annota-
tions, new species, and new reactions. Syntactic ontologies for the UniProtKB and the
PSI-MIF formats were created, while MFO was updated and BioPAX was used without
modification. Additionally, a telomere ontology was developed to model the biology
associated with the use cases. In the course of this work, not only have new biological
annotations been added, but we have discovered new biology by putatively identifying a
previously-unknown protein in the Proctor et al. model. Future work will use this
approach as the core of an automated semantically-aware model annotation system.
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